Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox
First Claim
Patent Images
1. A method of treating smallpox and other poxviruses in a mammalian patient in need thereof comprising administering a therapeutically effective dose of the compound 1,3,4-thiadiazole-cyanamide or a pharmaceutically acceptable salt or solvate thereof.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides methods of treating smallpox and other poxvirus infections with a pharmaceutically effective amount of LY582563 or LY217896.
-
Citations
2 Claims
-
1. A method of treating smallpox and other poxviruses in a mammalian patient in need thereof comprising administering a therapeutically effective dose of the compound 1,3,4-thiadiazole-cyanamide or a pharmaceutically acceptable salt or solvate thereof.
-
2. A method of treating smallpox and other poxviruses in a mammalian patient in need thereof comprising administering a therapeutically effective dose of the compound 2-amino-9-[2-[bis(2,2,2-trifluoroethyl)-phosphonylmethoxy]ethyl]-6-p-methoxyphenylthiopurine.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeJoseph Matthew Colacino
-
Original AssigneeJoseph Matthew Colacino
-
InventorsColacino, Joseph Matthew
-
Application NumberUS10/273,809Publication NumberTime in Patent OfficeDaysField of SearchUS Class Current514/81CPC Class CodesA61K 31/433 ThidiazolesA61K 31/675 having nitrogen as a ring h...
